Echocardiographic measures and subsequent decline in kidney function in older adults: the Atherosclerosis Risk in

Junichi Ishigami1, Lena Mathews1,2, Manabu Hishida1

  • 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2024 E. Monument St., Suite 2-600, Baltimore, MD 21287, USA.

Insights

Certain heart conditions, like increased left ventricular mass and reduced ejection fraction, significantly elevate the risk of developing chronic kidney disease (CKD) in older adults. Echocardiography can help assess this combined cardiac and kidney health risk.

Area of Science:

  • Cardiology
  • Nephrology
  • Geriatrics

Background:

  • Heart failure is a known risk factor for kidney disease progression.
  • The relationship between cardiac structure/function and incident chronic kidney disease (CKD) in community settings is not fully understood.

Purpose of the Study:

  • To investigate the association between echocardiographic measures of cardiac function and structure and the risk of developing incident CKD in an older, community-dwelling population.

Main Methods:

  • The Atherosclerosis Risk in Communities Study cohort (n=4188) without prevalent CKD was analyzed.
  • Echocardiographic measures including left ventricular (LV) mass index, ejection fraction, left atrial volume index (LAVi), and right ventricular (RV) function were assessed.
  • Incident CKD was defined by a >25% decline in estimated glomerular filtration rate (eGFR) to <60 mL/min/1.73 m², CKD hospitalization, or end-stage kidney disease.

Main Results:

  • Higher LV mass index, lower ejection fraction, higher LAVi, and higher peak RV-right atrium (RA) gradient were independently associated with an increased risk of incident CKD.
  • The risk of CKD increased monotonically with higher LV mass index, lower ejection fraction, higher LAVi, and higher peak RV-RA gradient.
  • No significant association was found between RV function and incident CKD risk.

Conclusions:

  • Cardiac structural and functional abnormalities, specifically LV mass index, ejection fraction, LAVi, and peak RV-RA gradient, are significant independent predictors of incident CKD in older adults.
  • These findings reinforce the link between heart disease and kidney disease progression.
  • Echocardiography may be valuable in assessing combined cardiovascular and kidney health in elderly populations.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
144
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
79
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
264
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
83
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
97
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
70